Australia, Nov. 18 -- KELONIA THERAPEUTICS Inc., owns the trademark (2537550) for 'KELONIATX' till April 7, 2035.
Status: registered:
Registered/protected
Classes: 5 [Pharmaceutical and medical preparations for use in cell and gene therapy for treatment of cancer and genetic diseases; Gene therapy and viral vectors for treatment of cancer and genetic diseases.], 42 [Providing medical and scientific research information; providing medical and scientific research information in the fields of pharmaceuticals and genetics; providing medical and scientific research information in the field of cell therapy; providing medical and scientific research information in the field of multiple myeloma; providing medical and scientific research information in the field of graft-versus-host disease.] and 44 [Providing medical information and medical treatments information; providing medical information in the field of cell therapy; providing medical information in the field of multiple myeloma; providing medical information in the field of graft-versus-host disease.]
Type of Mark: Word
Date of Acceptance: Sept. 10
Registration Advertised: Nov. 17
For further details contact AJ Park.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2537550.
Disclaimer: Curated by HT Syndication.
